EU Pharma Strategy Will Remove Barriers And Bolster Competition

Proposals Promise ‘Targeted Policies’ To Boost Generics And Biosimilars

The European Commission’s newly-published Pharmaceutical Strategy features a range of proposals related to generics and biosimilars, including “targeted policies” to improve competition, remove barriers and increase uptake.

Thumbs_Up_EU
The European Commission has published its Pharmaceutical Strategy proposals • Source: Shutterstock

“Targeted policies” aimed at improving the conditions for generic and biosimilar competition, removing barriers to market and increasing uptake and patient access have been put in motion by the European Commission as part of its Pharmaceutical Strategy for Europe announced today.

In a detailed document setting out its proposals, the Commission highlighted that “generic and biosimilar medicines provide a large...

Generics Bulletin Podcast

Stay ahead of every shift in generics and biosimilars.

Generics Bulletin brings you the latest updates that matter for the off-patent industry.

More from Policy & Regulation

More from Generics Bulletin